Vir Biotechnology (VIR) Capital Expenditures (2018 - 2026)
Vir Biotechnology's Capital Expenditures was $32,000 in Q2 2026, down 98.7% from $2.54 million a year earlier and down 91.8% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Capital Expenditures (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vir Biotechnology's Capital Expenditures was $1.09 million through Jun 30, 2026, down 87.8% year-over-year; for FY2025, it came in at $4.83 million, down 33.8% from FY2024.
- Capital Expenditures has now declined for three consecutive years, with a five-year compound annual growth rate of -5.9% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $7.3 million in FY2024 (-66.2%), $21.57 million in FY2023 (-68.3%), $68.01 million in FY2022 (+211.7%) and $21.82 million in FY2021 (+233.1%).
- The Q2 2026 figure marks the lowest quarterly Capital Expenditures in data going back to Q4 2018.
- Compared with a year earlier, Capital Expenditures has declined for four straight quarters, with an average decline of 9.2% over the last eight quarters.
- The best year-over-year quarter for Capital Expenditures over five years was Q2 2022 (growth of 891.7%); the worst was Q2 2026 (a decline of 98.7%).
- Per Business Quant data, VIR's Capital Expenditures in the three quarters before Q2 2026 was $390,000 (Q1 2026), $348,000 (Q4 2025) and $317,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Vir Biotechnology | 1.77 Bn | -185.85 Mn | 238.95 Mn | 32,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 390,000.00 |
| Dec 31, 2025 | 348,000.00 |
| Sep 30, 2025 | 317,000.00 |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 666,000.00 |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 3.71 Mn |
| Jun 30, 2023 | 9.46 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 12.57 Mn |
| Sep 30, 2022 | 18.99 Mn |
| Jun 30, 2022 | 20.60 Mn |
| Mar 31, 2022 | 15.84 Mn |
| Dec 31, 2021 | 13.07 Mn |
| Sep 30, 2021 | 6.01 Mn |
API Access
Vir Biotechnology Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();